News Theraclion

Equities

ALTHE

FR0010120402

Market Closed - Euronext Paris Other stock markets 11:35:29 2024-04-26 am EDT			5-day change	1st Jan Change
0.36 ^EUR	-1.10%		+4.35%	-7.22%

Mar. 27	Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Theraclion Achieves an Important Milestone on the Road to the U.S. Market: First Patients Treated with Sonovein as Part of the Fda- Approved Pivotal Study	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Theraclion Announces 2023 Financial Results and Continues Its Roadmap	Mar. 27	BU
Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
Theraclion : announces 2023 financial results and continues its roadmap	Mar. 27	PU
Theraclion : Présentation AGM – 29 juin 2023	Dec. 20	PU
Theraclion Achieves an Important Milestone on the Road to the U.S. Market: First Patients Treated with Sonovein as Part of the Fda- Approved Pivotal Study	23-10-24	CI
Theraclion SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-10-11	CI
Inner Mongolia Furui Medical Science Co., Ltd. agreed to acquire an additional 27.78% stake in Theraclion Medical Equipment Co., Ltd. from Theraclion SA for ?1	23-09-27	CI
Theraclion : Presentation AGM 29 juin 2023	23-07-24	PU
Theraclion: capital increase completed	23-06-23	CF
Theraclion SA announced that it has received â‚¬8.353961 million in funding from Furui Medical Science Company Luxembourg S.Ã r.l.	23-06-21	CI
Theraclion Names CEO	23-05-26	MT
Theraclion Appoints Martin Deterre as CEO	23-05-25	CI
Theraclion SA announced that it expects to receive €7 million in funding from Furui Medical Science Company Luxembourg S.à r.l.	23-05-24	CI
Theraclion SA announced that it expects to receive ?12.649999 million in funding from Furui Medical Science Company Luxembourg S.à r.l.	23-05-23	CI
Global markets live: HSBC, Logitech, Uber, IBM, BP...	23-05-02
Theraclion SA Auditor Raises 'Going Concern' Doubt	23-04-28	CI
Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
THERACLION : ANNOUNCES 2022 FINANCIAL RESULTS AND INFORMS ON THE COMPANY’S SHORT-TERM FINANCING	23-04-28	PU
Theraclion: FDA approves pivotal study with Sonovein	23-04-18	CF
France's Theraclion Gets US FDA Nod for Clinical Trial of Varicose Veins Treatment	23-04-18	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Theraclion

Equities

ALTHE

FR0010120402

Summary

Filters